Australia's Bioxyne jumps on unit securing manufacturing license for medical cannabis

BLS Pharmaceuticals

05/02/2024 24:17

** Shares of Bioxyne  BXN.AX  rise as much as 75% to
A$0.021, biggest gain since Aug. 20, 2020
    ** Health and wellness products co says its unit has been
awarded GMP manufacturing license for medical cannabis
    ** Stock at its highest since July 11
        ** About 40.2 mln shares change hands, compared with the
30-day average volume of 4.5 mln
    ** Stock fell 54.2% last year

 (Reporting by Neha Soni in Bengaluru)
 ((Neha.Soni@thomsonreuters.com))